NCT06960252 - Cycle-Length Mapping in Patients With Non-paroxysmal Atrial Fibrillation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2027

Conditions

Atrial Fibrillation (AF)

Interventions

DEVICE

OPTRELL™ Mapping Catheter

PVI plus substrate modification of LA chamber coexisting with low unipolar voltage (\< 3.0 mv) or bipolar voltage (\< 0.5 mv) in SR and stable (STD \< 30), fast AF CL detected by CLM module and OPTRELL™ Mapping Catheter.

Trial Locations (1)

112

RECRUITING

Taipei Veterans General Hospital, Taipei

All Listed Sponsors

lead

Ting-Yung Chang

OTHER_GOV